Omron, JP3196000008

Omron Corp stock (JP3196000008): Earnings report due May 14

Veröffentlicht: 12.05.2026 um 20:15 Uhr, Redaktion AD HOC NEWS, Redaktionelle Verantwortung: Rafael Müller (Chefredaktion)

Omron Corp (OMRNY) will release earnings on May 14, 2026, with consensus EPS at $0.75. The stock recently fell 2.94% to $26.39 on July 25, 2025, per market data.

Omron, JP3196000008, Illustration mit AI erstellt.
Omron, JP3196000008, Illustration mit AI erstellt.

Omron Corp, a leader in automation and healthcare devices, is set to report earnings on May 14, 2026, with analysts expecting EPS of $0.75, according to MarketBeat as of May 2026. This comes after the stock dropped 2.94% on July 25, 2025, closing at $26.39 from $27.19, as reported by StockInvest.us as of Jul 25, 2025. Investors watch for updates on industrial automation and healthcare segments amid US market exposure.

As of: 12.05.2026

By the editorial team – specialized in equity coverage.

At a glance

  • Name: Omron Corp
  • Sector/industry: Industrial Automation & Healthcare Devices
  • Headquarters/country: Japan
  • Core markets: Asia, US, Europe
  • Key revenue drivers: Sensors, robots, blood pressure monitors
  • Home exchange/listing venue: Tokyo Stock Exchange (OMRON); OTC US (OMRNY)
  • Trading currency: JPY (primary); USD (ADR)

Official source

For first-hand information on Omron Corp, visit the company’s official website.

Go to the official website

Omron Corp: core business model

Omron Corp develops sensing and control technologies for industrial automation, electronic components, social systems, and healthcare. Founded in 1933 in Kyoto, Japan, it serves factories, healthcare providers, and consumer markets globally. The company reported segments including Industrial Automation (over 50% of revenue), Electronic and Mechanical Components, Healthcare, and Others in its latest filings.

Key to its model is innovation in sensors, relays, and robotics, enabling efficient manufacturing. Omron's products support Industry 4.0 trends, with US relevance through exposure to American manufacturing resurgence and automation demand in sectors like automotive and logistics.

Main revenue and product drivers for Omron Corp

Industrial Automation drives majority revenue via factory automation devices, motion controllers, and collaborative robots. In November 2025, Omron Healthcare upgraded its VitalSight platform for remote monitoring, linking to Japan's infrastructure but with global potential including US telehealth growth, per OpenPR as of 2025.

Healthcare segment features blood pressure monitors and nebulizers, tapping into aging populations. Partnerships like Comau for industrial automation enhance robotics offerings, positioning Omron in warehouse robotics markets projected to grow from $8.3B in 2026 to $28.4B by 2034 at 16.6% CAGR, according to Intel Market Research as of May 12, 2026.

Industry trends and competitive position

Automation demand rises with labor shortages and e-commerce boom in the US. Omron competes with Rockwell Automation, Siemens, and Keyence, holding strengths in AI-integrated sensors. Recent leadership change: Virendra Shelar appointed CEO of Omron Europe, signaling expansion focus.

Why Omron Corp matters for US investors

Listed as OMRNY on OTC markets, Omron offers US investors access to Japan's tech without direct TSE trading. Its US operations support automation in key sectors like semiconductors and EVs, aligning with CHIPS Act investments and domestic manufacturing push.

Read more

Additional news and developments on the stock can be explored via the linked overview pages.

More news on this stockInvestor relations

Conclusion

Omron Corp approaches its May 14 earnings with focus on automation and healthcare growth amid recent price volatility. US investors note its ADR listing and sector exposure. Upcoming results and partnerships like Comau could shape near-term performance, though market trends remain key.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.

Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.

en | JP3196000008 | OMRON | boerse | 69316790 |